191 related articles for article (PubMed ID: 28099631)
1. Associations of cerebrovascular metabolism genotypes with neuropsychiatric symptoms and age at onset of Alzheimer's disease dementia.
Oliveira FF; Chen ES; Smith MC; Bertolucci PH
Braz J Psychiatry; 2017; 39(2):95-103. PubMed ID: 28099631
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer's dementia.
de Oliveira FF; Berretta JM; de Almeida Junior GV; de Almeida SS; Chen ES; Smith MC; Bertolucci PHF
Indian J Med Res; 2019 Sep; 150(3):261-271. PubMed ID: 31719297
[TBL] [Abstract][Full Text] [Related]
3. Selected LDLR and APOE Polymorphisms Affect Cognitive and Functional Response to Lipophilic Statins in Alzheimer's Disease.
de Oliveira FF; Chen ES; Smith MC; Bertolucci PHF
J Mol Neurosci; 2020 Oct; 70(10):1574-1588. PubMed ID: 32474901
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer's Disease Dementia.
de Oliveira FF; Chen ES; Smith MC; Bertolucci PHF
Curr Alzheimer Res; 2018 Feb; 15(4):386-398. PubMed ID: 29034839
[TBL] [Abstract][Full Text] [Related]
5. Behavioural effects of the
Oliveira FF; de Almeida SS; Smith MC; Bertolucci PHF
Cogn Neuropsychiatry; 2021 Jul; 26(4):293-305. PubMed ID: 34034613
[No Abstract] [Full Text] [Related]
6. Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease.
Panza F; Frisardi V; Seripa D; D'Onofrio G; Santamato A; Masullo C; Logroscino G; Solfrizzi V; Pilotto A
Ageing Res Rev; 2012 Jan; 11(1):87-103. PubMed ID: 21763789
[TBL] [Abstract][Full Text] [Related]
7. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
[TBL] [Abstract][Full Text] [Related]
8. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.
Rodríguez E; Mateo I; Infante J; Llorca J; Berciano J; Combarros O
J Neurol; 2006 Feb; 253(2):181-5. PubMed ID: 16096813
[TBL] [Abstract][Full Text] [Related]
9. The cholesteryl ester transfer protein (CETP) gene and the risk of Alzheimer's disease.
Arias-Vásquez A; Isaacs A; Aulchenko YS; Hofman A; Oostra BA; Breteler M; van Duijn CM
Neurogenetics; 2007 Aug; 8(3):189-93. PubMed ID: 17503098
[TBL] [Abstract][Full Text] [Related]
10. Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort.
Guven G; Vurgun E; Bilgic B; Hanagasi H; Gurvit H; Ozer E; Lohmann E; Erginel-Unaltuna N
Mol Biol Rep; 2019 Apr; 46(2):1701-1707. PubMed ID: 30684189
[TBL] [Abstract][Full Text] [Related]
11. Genetic influences on Alzheimer's disease: evidence of interactions between the genes APOE, APOC1 and ACE in a sample population from the South of Brazil.
Lucatelli JF; Barros AC; Silva VK; Machado Fda S; Constantin PC; Dias AA; Hutz MH; de Andrade FM
Neurochem Res; 2011 Aug; 36(8):1533-9. PubMed ID: 21533863
[TBL] [Abstract][Full Text] [Related]
12. APOE genotype in cerebrovascular disease and vascular dementia.
Frank A; Díez-Tejedor E; Bullido MJ; Valdivieso F; Barreiro P
J Neurol Sci; 2002 Nov; 203-204():173-6. PubMed ID: 12417379
[TBL] [Abstract][Full Text] [Related]
13. CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOE-dependent manner.
Murphy EA; Roddey JC; McEvoy LK; Holland D; Hagler DJ; Dale AM; Brewer JB;
Brain Imaging Behav; 2012 Mar; 6(1):16-26. PubMed ID: 21892657
[TBL] [Abstract][Full Text] [Related]
14. Distributions of ACE and APOE polymorphisms and their relations with dementia status in Korean centenarians.
Choi YH; Kim JH; Kim DK; Kim JW; Kim DK; Lee MS; Kim CH; Park SC
J Gerontol A Biol Sci Med Sci; 2003 Mar; 58(3):227-31. PubMed ID: 12634288
[TBL] [Abstract][Full Text] [Related]
15. The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.
D'Onofrio G; Panza F; Seripa D; Sancarlo D; Paris F; Cascavilla L; Urbano M; Gravina C; Fontana A; Solfrizzi V; Pellegrini F; Pilotto A
Int J Geriatr Psychiatry; 2011 Oct; 26(10):1062-70. PubMed ID: 21905100
[TBL] [Abstract][Full Text] [Related]
16. Contrasts Between Patients With Lewy Body Dementia Syndromes and APOE-ε3/ε3 Patients With Late-onset Alzheimer Disease Dementia.
Oliveira FF; Machado FC; Sampaio G; Marin SM; Chen ES; Smith MC; Bertolucci PH
Neurologist; 2015 Aug; 20(2):35-41. PubMed ID: 26280289
[TBL] [Abstract][Full Text] [Related]
17. Frequency of Cardiovascular Genetic Risk Factors in a Calabrian Population and Their Effects on Dementia.
Maletta R; Smirne N; Bernardi L; Anfossi M; Gallo M; Conidi ME; Colao R; Puccio G; Curcio SAM; Laganà V; Frangipane F; Cupidi C; Mirabelli M; Vasso F; Torchia G; Muraca MG; Di Lorenzo R; Rose G; Montesanto A; Passarino G; Bruni AC
J Alzheimers Dis; 2018; 61(3):1179-1187. PubMed ID: 29332048
[TBL] [Abstract][Full Text] [Related]
18. Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease.
Hollingworth P; Hamshere ML; Moskvina V; Dowzell K; Moore PJ; Foy C; Archer N; Lynch A; Lovestone S; Brayne C; Rubinsztein DC; Lawlor B; Gill M; Owen MJ; Williams J
J Am Geriatr Soc; 2006 Sep; 54(9):1348-54. PubMed ID: 16970641
[TBL] [Abstract][Full Text] [Related]
19. A multi-center study of ACE and the risk of late-onset Alzheimer's disease.
Belbin O; Brown K; Shi H; Medway C; Abraham R; Passmore P; Mann D; Smith AD; Holmes C; McGuinness B; Craig D; Warden D; Heun R; Kölsch H; Love S; Kalsheker N; Williams J; Owen MJ; Carrasquillo M; Younkin S; Morgan K; Kehoe PG
J Alzheimers Dis; 2011; 24(3):587-97. PubMed ID: 21297258
[TBL] [Abstract][Full Text] [Related]
20. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study.
van der Lee SJ; Wolters FJ; Ikram MK; Hofman A; Ikram MA; Amin N; van Duijn CM
Lancet Neurol; 2018 May; 17(5):434-444. PubMed ID: 29555425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
